Biotech analyst joins Forward Pharma as CFO
This article was originally published in Scrip
Copenhagen, Denmark-based Forward Pharma, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, has named Joel Sendek chief financial officer. Mr Sendek joins Forward Pharma from Stifel Financial where he was managing director, biotechnology, and led the firm's healthcare equity research group. Mr Sendek will serve as a key member of the executive team providing strategic leadership for the company's financial functions, and for its short and long-term financial objectives in support of the business strategy, Forward Pharma said.